Brokerages Set Privia Health Group, Inc. (NASDAQ:PRVA) PT at $24.86

Shares of Privia Health Group, Inc. (NASDAQ:PRVA) have been given a consensus rating of “Moderate Buy” by the fifteen ratings firms that are covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, twelve have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $24.86.

PRVA has been the subject of several recent research reports. Royal Bank of Canada reissued an “outperform” rating and issued a $28.00 price objective on shares of Privia Health Group in a research report on Wednesday, August 14th. Evercore ISI cut their price objective on Privia Health Group from $23.00 to $20.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 9th. Baird R W upgraded Privia Health Group to a “strong-buy” rating in a research note on Thursday, May 30th. Truist Financial lowered their target price on Privia Health Group from $28.00 to $24.00 and set a “buy” rating for the company in a research note on Wednesday, May 15th. Finally, Barclays reduced their price target on Privia Health Group from $22.00 to $19.00 and set an “equal weight” rating on the stock in a research report on Monday, May 20th.

Privia Health Group Stock Down 1.5 %

Shares of NASDAQ PRVA opened at $18.26 on Thursday. The stock has a market capitalization of $2.18 billion, a PE ratio of 121.73, a P/E/G ratio of 4.36 and a beta of 0.78. The firm has a fifty day moving average of $19.32 and a 200-day moving average of $18.81. Privia Health Group has a 52-week low of $15.92 and a 52-week high of $25.92.

Privia Health Group (NASDAQ:PRVA) last released its quarterly earnings data on Thursday, August 8th. The company reported $0.03 EPS for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.02). The firm had revenue of $422.30 million during the quarter, compared to analysts’ expectations of $411.50 million. Privia Health Group had a return on equity of 2.42% and a net margin of 0.88%. The business’s revenue for the quarter was up 2.2% compared to the same quarter last year. During the same quarter last year, the business earned $0.06 earnings per share. Equities research analysts expect that Privia Health Group will post 0.16 EPS for the current fiscal year.

Institutional Investors Weigh In On Privia Health Group

Institutional investors have recently modified their holdings of the stock. Canada Pension Plan Investment Board acquired a new stake in Privia Health Group during the second quarter valued at approximately $26,000. Nisa Investment Advisors LLC raised its position in shares of Privia Health Group by 107.5% during the 2nd quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company’s stock valued at $31,000 after acquiring an additional 930 shares in the last quarter. Signaturefd LLC lifted its stake in Privia Health Group by 46.3% during the second quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock worth $34,000 after purchasing an additional 626 shares during the last quarter. Park Place Capital Corp boosted its holdings in Privia Health Group by 115.4% in the first quarter. Park Place Capital Corp now owns 2,492 shares of the company’s stock worth $49,000 after purchasing an additional 1,335 shares during the period. Finally, Covestor Ltd increased its stake in Privia Health Group by 25.5% during the first quarter. Covestor Ltd now owns 5,292 shares of the company’s stock valued at $104,000 after purchasing an additional 1,076 shares during the last quarter. Institutional investors and hedge funds own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.